According to previous reports on MIBC, erbB2 overexpression is an independent risk factor for cancer death in patients undergoing radical cystectomy [28] and an independent predictor of non-CR after CRT but not a risk factor for cancer death in patients treated with CRT [8]. Here, ERBB2 is linked to cancer.